Incremental Costs for Psoriasis and Psoriatic Arthritis in a Population-based Cohort in Southern Sweden: Is It All Psoriasis-attributable Morbidity?

The Journal of Rheumatology
Sofia LöfvendahlKatarina Steen Carlsson

Abstract

To estimate incremental costs for patients with psoriasis/psoriatic arthritis (PsO/PsA) compared to population-based referents free from PsO/PsA and estimate costs attributable specifically to PsO/PsA. Patients were identified by International Classification of Diseases, 10th ed., codes for PsO/PsA using information from 1998 to 2007 in the Skåne Healthcare Register, covering healthcare use for the population of the Skåne region of Sweden. For each patient, 3 population-based referents were selected. Data were retrieved from Swedish registers on healthcare, drugs, and productivity loss. The human capital method was used to value productivity losses. Mean annual costs for 2008 to 2011 were assessed from a societal perspective. We identified 15,283 patients fulfilling the inclusion criteria for PsO [n = 12,562, 50% women, mean age (SD) 52 (21) yrs] or PsA [n = 2721, 56% women, mean age 54 (16) yrs] and included 45,849 referents. Mean annual cost per patient with PsO/PsA was 55% higher compared to referents: €10,500 vs €6700. The cost was 97% higher for PsA compared to PsO. Costs due to productivity losses represented the largest share of total costs, ranging from 52% for PsO to 60% for PsA. Biological drug costs represented 10% o...Continue Reading

References

Jul 20, 1999·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·K NarbroL Sjöström
Apr 16, 2004·The Journal of Investigative Dermatology. Symposium Proceedings·Robert S SternTara Rolstad
Sep 1, 2006·PharmacoEconomics·Ebere AkobunduC Daniel Mullins
Nov 21, 2007·Annals of the Rheumatic Diseases·Gisela Kobelt
May 31, 2008·Annals of the Rheumatic Diseases·M WalleniusT K Kvien
Aug 30, 2008·Therapeutics and Clinical Risk Management·Gl ColomboS Chimenti
Oct 7, 2008·Journal of the American Academy of Dermatology·Murat IcenHilal Maradit Kremers
Jan 3, 2009·Journal of the American Academy of Dermatology·Joseph F FowlerGeorge Kosicki
Feb 19, 2009·Dermatologic Therapy·Dafna D Gladman
Aug 12, 2009·Current Medical Research and Opinion·Andrew P YuParvez M Mulani
Aug 29, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·D PathiranaB Rzany
Sep 23, 2009·Journal of Cutaneous Medicine and Surgery·Charles W LyndeChristine Jackson
Dec 26, 2009·Journal of Autoimmunity·Vinod Chandran, Siba P Raychaudhuri
Mar 20, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·N MeyerJ P Ortonne
Jun 22, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·A B KimballP M Mulani
Jul 4, 2012·The Journal of Rheumatology. Supplement·Ramani Arumugam, Neil J McHugh
Sep 28, 2012·The Journal of Investigative Dermatology·Rosa ParisiUNKNOWN Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team
Nov 23, 2012·International Journal of Dermatology·Adrian R LevyCharles W Lynde
Apr 6, 2013·European Journal of Dermatology : EJD·Kalle MattilaRisto Tuominen
Jun 19, 2013·American Journal of Clinical Dermatology·Wolf-Henning Boehncke, Alan Menter
Jun 28, 2013·Rheumatology·Emma HaglundIngemar F Petersson
Aug 27, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Kristina BurströmNiklas Zethraeus
Aug 29, 2013·Journal of the American Academy of Dermatology·Philip J MeaseDaniel Alvarez
May 14, 2014·Acta Dermato-venereologica·Jenny M NorlinMarcus Schmitt-Egenolf
May 29, 2014·Dermatology and Therapy·A MustonenR Tuominen
Jul 24, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Steven R FeldmanUsha G Mallya
Apr 19, 2015·BMC Health Services Research·Anssi MustonenRisto Tuominen

❮ Previous
Next ❯

Citations

May 21, 2017·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Sofia LöfvendahlKatarina Steen Carlsson
Feb 15, 2018·PharmacoEconomics·Lucia Sara D'AngiolellaLorenzo Giovanni Mantovani
May 17, 2019·The Journal of Dermatological Treatment·Jonathan BarkerTaegyun Kang
Dec 10, 2019·Scandinavian Journal of Public Health·Sofia LöfvendahlAnna Jöud
Sep 1, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·D JungenM Gutknecht

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.